Tobias R. Kollmann

Tobias R. Kollmann is a Professor in the Department of Microbiology & Immunology and Pediatrics at Dalhousie University, Canada. He is also the founder and CEO of the Born Strong Initiative, a global network addressing adverse pregnancy outcomes. His research focuses on immune ontogeny, maternal and neonatal host responses, and systems vaccinology, leveraging cutting-edge technologies like systems biology and AI. Kollmann has held leadership roles, including Division Head at the University of British Columbia and Director at the Telethon Kids Institute in Australia.

Education: MD and PhD from Albert Einstein College of Medicine, followed by pediatric residency and infectious diseases fellowship at the University of Washington. His work spans clinical and translational research, emphasizing global health in low-resource settings.

Research interests include neonatal sepsis mechanisms, non-specific vaccine effects, and leveraging omics data to predict immune responses. Key projects include the 'Born Strong' initiative and studies on BCG vaccine's heterologous effects. He leads grants from organizations like Open Philanthropy and the Human Vaccines Project.

Awards include membership in the WHO Expert Advisory Group on Non-specific Immunological Effects of Vaccination. His lab is part of the Canadian Centre for Vaccinology, collaborating globally on maternal and child health challenges.